Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 174.45%, near the low end of its 5-year range (0.00%–696.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 1.33%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
1.33%
DEBT TO ASSETS RATIO AVG 3Y
16.67%
DEBT TO ASSETS RATIO AVG 5Y
174.45%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 808 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
SeaStar Medical Holding Corporation
Market Cap
$9.31M
Debt to Assets Ratio
0.00%
TTM Avg
1.33%
3Y Avg
16.67%
5Y Avg
174.45%
Market Cap
$9.57M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.32M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.16M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.08M
Debt to Assets Ratio
0.80%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.33M
Debt to Assets Ratio
0.61%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.31M | 0.00% | 1.33% | 16.67% | 174.45% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.57M | 0.01% | N/A | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.32M | 0.07% | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.71M | 0.71% | N/A | N/A | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.16M | 0.02% | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.88M | 0.01% | N/A | N/A | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.08M | 0.80% | N/A | N/A | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.33M | 0.61% | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.58M | 1.00% | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.34M | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
1.89
Interest Coverage
-37.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 2.94% |
| 2025-12-31 | 3.71% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 4.78% |
| 2024-12-31 | 12.32% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 90.57% |
| 2024-03-31 | 52.42% |
| 2023-12-31 | 258.50% |
| 2023-09-30 | 450.69% |
| 2023-06-30 | 348.63% |
| 2023-03-31 | 254.81% |
| 2022-12-31 | 290.65% |
| 2022-09-30 | 446.25% |
| 2022-06-30 | 315.58% |
| 2022-03-31 | 696.72% |
| 2021-12-31 | 434.83% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 46.96% |
